top biopharmaceuticals for glp-1 medication 3 Companies at the Forefront of the Pill Wars The incorporation of probiotics for gut health adds an extra layer of appeal 2025 Pharma Trends: Keytruda, Mounjaro,

N., Goes, C

2021;35(4):e22697

In contrast to these studies, there were four particular studies which concluded a higher rate of aspiration and regurgitation events among GLP-1 RA users compared to non-users (Australian Diabetes Society, National Association of Clinical Obesity Services, Gastroenterological Society of Australia, and Australian and New Zealand College of Anaesthetists n.d.)

References Chorev M, Shavitz R, Goodman M, Minick S, Guillemin R

37 RCTs Meta-Analysis (2020) Weight loss: -1.13 kg BMI: -0.36 points Fat mass: -1.16 kg Waist circumference: -1.24 cm Umbrella Meta-Analysis (2025) Confirms: statistically significant weight loss , especially combined with exercise